A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042)
Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
Patients undergo 4-week placebo lead-in and diet period, and 12-week treatment period.
Clinical efficacy and safety is evaluated at weeks 4, 8 and 12. This study takes
approximately 18 weeks for an individual patient to complete including post-visit at week 14.